keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KSPWFTTL is an immunodominant epitope derived from the p15E transmembrane protein. It is Kb-restricted and can enhance the susceptibility of a tumor cell line to cytotoxic T lymphocytes targeting anti-AKR/Gross MuLV.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | KSPWFTTL is an immunodominant epitope derived from the p15E transmembrane protein. It is Kb-restricted and can enhance the susceptibility of a tumor cell line to cytotoxic T lymphocytes targeting anti-AKR/Gross MuLV. |
In vitro | KSPWFTTL, originating from the retroviral p15 TM envelope protein, sensitizes the previously resistant cl.18-5 clonal line to cytolytic T-lymphocyte (CTL) induced lysis upon pulsing with the peptide, thereby rendering these cells vulnerable to destruction by antiviral CTLs[2]. |
Molecular Weight | 979.146 |
Formula | C48H70N10O12 |
CAS No. | 153049-05-9 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KSPWFTTL 153049-05-9 inhibitor inhibit